Rare diseases
Investigational molecules
Locations
Back to France23 clinical trials in Libourne, France. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)FranceFranceFranceFranceFranceFranceFranceFranceFranceFranceFranceFranceThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on Multiple Sclerosis treatment strategies, including studies on anti-CD20 therapy de-escalation and disease-modifying therapies in secondary progressive cases.
Research aims to improve long-term patient outcomes and treatment effectiveness.
Advanced studies in Multiple Myeloma and B-cell Lymphoma, evaluating novel therapeutic combinations and maintenance strategies.
Trials focus on improving survival rates and treatment responses in blood disorders.
Research addressing Atrial Fibrillation and acute coronary syndrome management, utilizing innovative monitoring technologies and anticoagulation strategies.
Studies aim to enhance treatment safety and patient monitoring effectiveness.
Clinical investigations in severe asthma management, including new treatment formulations and therapeutic approaches for different patient populations.
Focus on developing safer and more effective respiratory treatments.
Comprehensive research on Rheumatoid Arthritis, Behçet's Disease, and other inflammatory conditions, testing novel therapeutic combinations.
Studies evaluate innovative approaches to managing complex autoimmune conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
